No recent analyst price targets found for CUBT.
Latest News for CUBT
Curative Biotechnology, Inc. Issues Letter to Shareholders
Company Reviews Significant Ophthalmology, Intellectual Property and Translational Development Milestones Achieved Over the Past Year Palm Beach Gardens, FL, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) ("Curative" or the "Company"), a development-stage biomedical company advancing topical metformin-based ophthalmic therapies for degenerative eye diseases, today issued the following…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for CUBT.
Senate Trading
No Senate trades found for CUBT.
U.S. House Trading
No House trades found for CUBT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.